The FDA has determined that products from PT. Bahari Makmur Sejati violate the Federal Food, Drug, & Cosmetic Act by appearing to have been prepared, packed or held under insanitary conditions wherei...

The primary health risk is through long-term, repeated low-dose exposure, which can increase the risk of cancer.